API Manufacturing

With a successful performance record of over 40 years, we manufacture and supply Active Pharmaceutical Ingredients (APIs) through our sites in North America, Europe, and Asia markets. Our API facilities are inspected and approved by global regulatory bodies, including the US FDA, Japan PMDA, and UK MHRA, and meet the cGMP compliance standards.

We are the preferred partner for big pharma and biotech companies across North America and Europe with the total reactor volume exceeding 500 KL (including pilot and multi-purpose plants). We have a record of accomplishment of over 30 Launches and are capable of executing extensive small molecule API requirements.